166 related articles for article (PubMed ID: 20407663)
1. [Echinocandins and the 2009 guidelines for treatment of candidiasis].
Melo LH
Drugs Today (Barc); 2010 Mar; 46 Suppl B():7-12. PubMed ID: 20407663
[TBL] [Abstract][Full Text] [Related]
2. The echinocandins: three useful choices or three too many?
Bal AM
Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
[TBL] [Abstract][Full Text] [Related]
3. Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins.
Hori Y; Shibuya K
Med Mycol J; 2018; 59(2):E31-E40. PubMed ID: 29848909
[TBL] [Abstract][Full Text] [Related]
4. Echinocandin Resistance in Candida.
Perlin DS
Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S612-7. PubMed ID: 26567278
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of candidemia and invasive candidiasis according to guidelines].
Glöckner A
Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
[TBL] [Abstract][Full Text] [Related]
6. [Current treatment of candidemia. Role of anidulafungin].
Almirante B; Pemán J
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():21-8. PubMed ID: 19572431
[TBL] [Abstract][Full Text] [Related]
7. Micafungin for the prophylaxis and treatment of Candida infections.
Fritz JM; Brielmaier BD; Dubberke ER
Expert Rev Anti Infect Ther; 2008 Apr; 6(2):153-62. PubMed ID: 18380597
[TBL] [Abstract][Full Text] [Related]
8. Echinocandins: the newest class of antifungals.
Sucher AJ; Chahine EB; Balcer HE
Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
[TBL] [Abstract][Full Text] [Related]
9. Development of New Strategies for Echinocandins: Progress in Translational Research.
Walsh TJ; Azie N; Andes DR
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S601-3. PubMed ID: 26567276
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antifungal evaluation of pentyloxyl-diphenylisoxazoloyl pneumocandins and echinocandins.
Singh SB; Herath K; Kahn JN; Mann P; Abruzzo G; Motyl M
Bioorg Med Chem Lett; 2013 Jun; 23(11):3253-6. PubMed ID: 23623416
[TBL] [Abstract][Full Text] [Related]
11. Echinocandins: a wealth of choice--how clinically different are they?
Zaas AK
Curr Opin Infect Dis; 2008 Aug; 21(4):426-32. PubMed ID: 18594297
[TBL] [Abstract][Full Text] [Related]
12. Anidulafungin: a novel echinocandin for candida infections.
de la Torre P; Meyer DK; Reboli AC
Future Microbiol; 2008 Dec; 3(6):593-601. PubMed ID: 19072176
[TBL] [Abstract][Full Text] [Related]
13. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.
Beyda ND; Lewis RE; Garey KW
Ann Pharmacother; 2012; 46(7-8):1086-96. PubMed ID: 22811350
[TBL] [Abstract][Full Text] [Related]
14. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the diagnosis and treatment of yeast infections: role of the new antifungal agents].
Pemán J; Almirante B
Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():38-46. PubMed ID: 19100166
[TBL] [Abstract][Full Text] [Related]
16. [Echinocandins in invasive candidiasis].
Glöckner A; Cornely OA
Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
[TBL] [Abstract][Full Text] [Related]
17. Candidemia in children.
Zaoutis T
Curr Med Res Opin; 2010 Jul; 26(7):1761-8. PubMed ID: 20513207
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin for the treatment of pediatric fungal infections.
Fisher BT; Zaoutis T
Pediatr Infect Dis J; 2008 Dec; 27(12):1099-102. PubMed ID: 19057369
[No Abstract] [Full Text] [Related]
19. Treatment of invasive candidiasis with echinocandins.
Glöckner A; Steinbach A; Vehreschild JJ; Cornely OA
Mycoses; 2009 Nov; 52(6):476-86. PubMed ID: 19076282
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology and antifungal properties of anidulafungin, a new echinocandin.
Estes KE; Penzak SR; Calis KA; Walsh TJ
Pharmacotherapy; 2009 Jan; 29(1):17-30. PubMed ID: 19113794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
